PAX2 and melanoma: The effect of methylation on MZF1-targeted DNA binding motifs has previously been described for the reprogramming key gene OCT4 in induced pluripotent stem cells [86], the PAX2 gene in endometrial cancer [87], and the tumour antigen PRAME (preferentially expressed antigen in melanoma) in melanoma cells [88].